Severe Drug Toxicity Associated with a Single-Nucleotide Polymorphism of the Cytidine Deaminase Gene in a Japanese Cancer Patient Treated with Gemcitabine plus Cisplatin-Reference-Cited by-同舟云学术

Severe Drug Toxicity Associated with a Single-Nucleotide Polymorphism of the Cytidine Deaminase Gene in a Japanese Cancer Patient Treated with Gemcitabine plus Cisplatin

Published:2005-04-01 Issue:7 Volume:11 Page:2620-2624
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Yonemori Kan,Ueno Hideki,Okusaka Takuji,Yamamoto Noboru,Ikeda Masafumi,Saijo Nagahiro,Yoshida Teruhiko,Ishii Hiroshi,Furuse Junji,Sugiyama Emiko,Kim Su-Ryang,Kikura-Hanajiri Ruri,Hasegawa Ryuichi,Saito Yoshiro,Ozawa Shogo,Kaniwa Nahoko,Sawada Jun-ichi

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nucleo(s)tide metabolism as basis for drug development; the Anne Simmonds award lecture;Nucleosides, Nucleotides & Nucleic Acids;2024-08

2. Personalized medicine of non-gene-specific chemotherapies for non-small cell lung cancer;Acta Pharmaceutica Sinica B;2021-11

3. Pharmacoethnicity of FOLFIRINOX versus gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer: a systematic review and meta-analysis;Scientific Reports;2021-10-11

4. Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel;The Pharmacogenomics Journal;2021-01-18

5. Cytidine deaminase 435C>T polymorphism relates to gemcitabine-platinum efficacy and hematological toxicity in Chinese non-small-cell lung cancer patients;Neoplasma;2021